Advanced Medical Solutions, often referred to as AMS, is a leading provider of innovative medical technologies headquartered in Great Britain. Established in 1992, the company has made significant strides in the healthcare sector, particularly in wound care and advanced surgical solutions. With a strong presence in Europe and expanding operations in North America, AMS is renowned for its commitment to enhancing patient outcomes through cutting-edge products. The company’s core offerings include advanced wound care dressings, surgical adhesives, and innovative biomaterials, all designed to promote healing and improve surgical efficiency. What sets AMS apart is its focus on research and development, ensuring that its products are at the forefront of medical advancements. Recognised for its quality and reliability, Advanced Medical Solutions continues to solidify its position as a trusted partner in the global healthcare market.
How does Advanced Medical Solutions's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Advanced Medical Solutions's score of 52 is higher than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Advanced Medical Solutions (AMS) reported total carbon emissions of approximately 16,890,400 kg CO2e in Great Britain, with Scope 1 emissions at about 2,409,000 kg CO2e and Scope 2 emissions at approximately 835,190 kg CO2e. The company also disclosed significant Scope 3 emissions, totalling about 98,907,000 kg CO2e, which includes categories such as purchased goods and services (approximately 43,512,000 kg CO2e) and upstream transportation and distribution (about 8,055,000 kg CO2e). AMS has set ambitious climate commitments, aiming for a 42% absolute reduction in Scope 1 and 2 greenhouse gas emissions by 2030, using 2021 as the baseline year. Furthermore, the company is committed to achieving Net Zero emissions across all scopes by 2045. These targets reflect AMS's dedication to sustainability and align with industry standards for climate action. The emissions data is sourced from Advanced Medical Solutions Group plc, ensuring transparency and accountability in their environmental impact reporting.
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Scope 1 | 565,517 | 0,000,000 | 0,000,000 | 0,000,000 | - |
| Scope 2 | 1,310,640 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 22,838 | 00,000,000 | 000,000 | 00,000,000 | 00,000,000 |
Advanced Medical Solutions's Scope 3 emissions, which increased by 96% last year and increased significantly since 2020, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 44% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Advanced Medical Solutions has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Common questions about Advanced Medical Solutions's sustainability data and climate commitments